May 14, 2024 / 12:30PM GMT
Operator
Good morning and welcome to Mink Therapeutics first quarter 2024 conference call and webcast. (Operator Instructions) Please note, this event is being recorded. If anyone has any objections, you may disconnect at this time.
I would now like to turn the conference over to Zach Armen from Mink's Investor Relations. Zach, please go ahead.
Zack Armen - Mink Therapeutics Inc - Head of Investor Relations
Thank you, operator, and thank you all for joining us today. Today's call is being webcast and will be available on our website for replay. I'd like to remind you that this call will include forward-looking statements, including statements regarding our clinical development, regulatory and commercial plans and time lines as well as time lines for data release and partnership opportunities and other updates.
These statements are subject to risks and uncertainties, and we refer you to our SEC filings available on our website for more detail on these risks. Joining me today are Dr. Jennifer Buell, President and Chief Executive Officer; Dr. Marc Van
Q1 2024 Mink Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot